New Enterprise Associates 17, L.P. is 10% at Korro Bio, Inc. (KRRO). They have made 1 open-market trade across 1 company since 2024, most recently 2026-03-10.
CIK 0001768564
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.3M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGP | 6,035,038 | $145.6M |
| KRRO | 1,297,893 | $11.3M |
| NEUE | 123,729 | $836K |
| Total | $157.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRRO | BUY | 2026-03-10 | 2026-03-12 | $11.11 | $2.3M | -23.3% | -0.7% | -23.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.